FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Laure Morin-Papunen

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Biological Markers

Co-author Network

Publications

TOP 3
Henri Sova; Laure Morin-Papunen; Ulla Puistola; Peeter Karihtala
Metformin decreases serum 8-hydroxy-2'-deoxyguanosine levels in polycystic ovary syndrome.
P Pinola; A Pouta; Katri Puukka; Aimo Ruokonen; M Ulmanen; A Bloigu; S Franks; A-L Hartikainen; M-R Järvelin; H Lashen; H Martikainen; Laure Morin-Papunen
Menstrual disorders in adolescence: a marker for hyperandrogenaemia and increased metabolic risks in later life? Finnish general population-based birth cohort study.
Terhi Piltonen; J Puurunen; Aimo Ruokonen; P Hedberg; K H Herzig; Laure Morin-Papunen; S J Mutt; A Nissinen; Juha S Tapanainen
Oral, transdermal and vaginal combined contraceptives induce an increase in markers of chronic inflammation and impair insulin sensitivity in young healthy normal-weight women: a randomized study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Laure Morin-Papunen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Henri Sova; Laure Morin-Papunen; Ulla Puistola; Peeter Karihtala
Metformin decreases serum 8-hydroxy-2'-deoxyguanosine levels in polycystic ovary syndrome.
Fertility and sterility 2013;99(2):593-8.
2012: P Pinola; A Pouta; Katri Puukka; Aimo Ruokonen; M Ulmanen; A Bloigu; S Franks; A-L Hartikainen; M-R Järvelin; H Lashen; H Martikainen; Laure Morin-Papunen
Menstrual disorders in adolescence: a marker for hyperandrogenaemia and increased metabolic risks in later life? Finnish general population-based birth cohort study.
Human reproduction (Oxford, England) 2012;27(11):3279-86.
2012: Terhi Piltonen; J Puurunen; Aimo Ruokonen; P Hedberg; K H Herzig; Laure Morin-Papunen; S J Mutt; A Nissinen; Juha S Tapanainen
Oral, transdermal and vaginal combined contraceptives induce an increase in markers of chronic inflammation and impair insulin sensitivity in young healthy normal-weight women: a randomized study.
Human reproduction (Oxford, England) 2012;27(10):3046-56.
2012: Laure Morin-Papunen; Antti Perheentupa; Katri Puukka; Anni S Rantala; Aimo Ruokonen; Risto Bloigu; Maritta Hippeläinen; Aila Tiitinen; Helena Tinkanen; Leila Unkila-Kallio; Juha S Tapanainen
Metformin improves pregnancy and live-birth rates in women with polycystic ovary syndrome (PCOS): a multicenter, double-blind, placebo-controlled randomized trial.
The Journal of clinical endocrinology and metabolism 2012;97(5):1492-500.
2012: Taina K Lajunen; Laure Morin-Papunen; Anna-Kaisa Purhonen; Katri Puukka; Aimo Ruokonen; Markku J Savolainen; Juha S Tapanainen; Stephen Franks; Marianne Haapea; Anna-Liisa Hartikainen; Marjo-Riitta Järvelin; Karl-Heinz Herzig
Full-length visfatin levels are associated with inflammation in women with polycystic ovary syndrome.
European journal of clinical investigation 2012;42(3):321-8.
2012: Laure Morin-Papunen; Riitta Koivunen
[Treatment of infertility--part II (male infertility)].
Duodecim; lääketieteellinen aikakauskirja 2012;128(15):1568-75.
2012: Laure Morin-Papunen; Riitta Koivunen
[Treatment of infertility].
Duodecim; lääketieteellinen aikakauskirja 2012;128(14):1478-85.
2011: Assi Torvinen; Anneli Pouta; Aimo Ruokonen; Aini Bloigu; Stephen Franks; Anna-Liisa Hartikainen; Marjo-Riitta Järvelin; Riitta Koivunen; Hannu Martikainen; Mark I McCarthy; Laure Morin-Papunen
Metabolic and reproductive characteristics of first-degree relatives of women with self-reported oligo-amenorrhoea and hirsutism.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2011;27(9):630-5.
2011: Johanna Puurunen; Terhi Piltonen; Laure Morin-Papunen; Antti Perheentupa; Ilkka Järvelä; Aimo Ruokonen; Juha S Tapanainen
Unfavorable hormonal, metabolic, and inflammatory alterations persist after menopause in women with PCOS.
The Journal of clinical endocrinology and metabolism 2011;96(6):1827-34.
2011: H Ijäs; Marja Vääräsmäki; Laure Morin-Papunen; R Keravuo; T Ebeling; T Saarela; Tytti Raudaskoski
Metformin should be considered in the treatment of gestational diabetes: a prospective randomised study.
BJOG : an international journal of obstetrics and gynaecology 2011;118(7):880-5.
2011: Maarit Matilainen; Sini Peuhkurinen; Päivi Laitinen; Ilkka Jarvela; Laure Morin-Papunen; Markku Ryynanen
In combined first-trimester Down syndrome screening, the false-positive rate is not higher in pregnancies conceived after assisted reproduction compared with spontaneous pregnancies.
Fertility and sterility 2011;95(1):378-81.
2010: Henri Sova; Laure Morin-Papunen; Ulla Puistola; Peeter Karihtala
Distinctively low levels of serum 8-hydroxydeoxyguanosine in women with polycystic ovary syndrome.
Fertility and sterility 2010;94(7):2670-3.
2010: Laure Morin-Papunen; Antoni J Duleba; Aini Bloigu; Marjo-Riitta Järvelin; Pekka Saikku; Anneli Pouta
Chlamydia antibodies and self-reported symptoms of oligo-amenorrhea and hirsutism: a new etiologic factor in polycystic ovary syndrome?
Fertility and sterility 2010;94(5):1799-804.
2010: Marja Ojaniemi; Päivi Tapanainen; Laure Morin-Papunen
Management of polycystic ovary syndrome in childhood and adolescence.
Hormone research in pædiatrics 2010;74(5):372-5.
2009: Johanna Puurunen; Terhi Piltonen; Päivi Jaakkola; Aimo Ruokonen; Laure Morin-Papunen; Juha S Tapanainen
Adrenal androgen production capacity remains high up to menopause in women with polycystic ovary syndrome.
The Journal of clinical endocrinology and metabolism 2009;94(6):1973-8.
2009: Hanna Ebeling; Leea Järvi; Jorma Komulainen; Minna Koskinen; Laure Morin-Papunen; Aila Rissanen; Päivi Tapanainen
[Update on current care guidelines. Eating disorders in children and adolescents].
Duodecim; lääketieteellinen aikakauskirja 2009;125(22):2466-7.
2008: Laure Morin-Papunen; Hannu Martikainen; Mark I McCarthy; Stephen Franks; Ulla Sovio; Anna-Liisa Hartikainen; Aimo Ruokonen; Maija Leinonen; Jaana Laitinen; Marjo-Riitta Järvelin; Anneli Pouta
Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population.
American journal of obstetrics and gynecology 2008;199(5):529.e1-529.e10.
2007: A Majuri; Merja Santaniemi; Katrina Rautio; Anne Kunnari; Juhani Vartiainen; Aimo Ruokonen; Y Antero Kesäniemi; Juha S Tapanainen; Olavi Ukkola; Laure Morin-Papunen
Rosiglitazone treatment increases plasma levels of adiponectin and decreases levels of resistin in overweight women with PCOS: a randomized placebo-controlled study.
European journal of endocrinology / European Federation of Endocrine Societies 2007;156(2):263-9.
2007: Katrina Rautio; Juha S Tapanainen; Aimo Ruokonen; Laure Morin-Papunen
Rosiglitazone treatment alleviates inflammation and improves liver function in overweight women with polycystic ovary syndrome: a randomized placebo-controlled study.
Fertility and sterility 2007;87(1):202-6.
2006: Katrina Rautio; Juha S Tapanainen; Aimo Ruokonen; Laure Morin-Papunen
Endocrine and metabolic effects of rosiglitazone in overweight women with PCOS: a randomized placebo-controlled study.
Human reproduction (Oxford, England) 2006;21(6):1400-7.
2005: Terhi Piltonen; Laure Morin-Papunen; Riitta Koivunen; Antti Perheentupa; Aimo Ruokonen; Juha S Tapanainen
Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Human reproduction (Oxford, England) 2005;20(7):1820-6.
2005: Katrina Rautio; Juha S Tapanainen; Aimo Ruokonen; Laure Morin-Papunen
Effects of metformin and ethinyl estradiol-cyproterone acetate on lipid levels in obese and non-obese women with polycystic ovary syndrome.
European journal of endocrinology / European Federation of Endocrine Societies 2005;152(2):269-75.
2005: Laure Morin-Papunen; Päivi Tapanainen
[How obesity of girls during childhood and adolescent reflects to reproductive ability].
Duodecim; lääketieteellinen aikakauskirja 2005;121(17):1899-907.
2004: Terhi Piltonen; Riitta Koivunen; Antti Perheentupa; Laure Morin-Papunen; Aimo Ruokonen; Juha S Tapanainen
Ovarian age-related responsiveness to human chorionic gonadotropin in women with polycystic ovary syndrome.
The Journal of clinical endocrinology and metabolism 2004;89(8):3769-75.
2004: Laure Morin-Papunen; Ilkka Vauhkonen; Aimo Ruokonen; Juha S Tapanainen; Tytti Raudaskoski
Effects of tibolone and cyclic hormone replacement therapy on glucose metabolism in non-diabetic obese postmenopausal women: a randomized study.
European journal of endocrinology / European Federation of Endocrine Societies 2004;150(5):705-14.
2003: Laure Morin-Papunen; Katrina Rautio; Aimo Ruokonen; Pirjo Hedberg; Matti J Puukka; Juha S Tapanainen
Metformin reduces serum C-reactive protein levels in women with polycystic ovary syndrome.
The Journal of clinical endocrinology and metabolism 2003;88(10):4649-54.
2003: Hanna Ebeling; Paivi Tapanainen; Auli Joutsenoja; Minna Koskinen; Laure Morin-Papunen; Leea Järvi; Riitta Hassinen; Anna Keski-Rahkonen; Aila Rissanen; Kristian Wahlbeck
A practice guideline for treatment of eating disorders in children and adolescents.
Annals of medicine 2003;35(7):488-501.
2003: Laure Morin-Papunen; Ilkka Vauhkonen; Riitta Koivunen; Aimo Ruokonen; Hannu Martikainen; Juha S Tapanainen
Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study.
The Journal of clinical endocrinology and metabolism 2003;88(1):148-56.
2002: Terhi Piltonen; Riitta Koivunen; Laure Morin-Papunen; Aimo Ruokonen; Ilpo T Huhtaniemi; Juha S Tapanainen
Ovarian and adrenal steroid production: regulatory role of LH/HCG.
Human reproduction (Oxford, England) 2002;17(3):620-4.
2002: Riitta Koivunen; Laure Morin-Papunen
[Insulin resistance and infertility].
Duodecim; lääketieteellinen aikakauskirja 2002;118(5):509-15.
2001: Riitta Koivunen; Laure Morin-Papunen; Aimo Ruokonen; Juha S Tapanainen; Hannu Martikainen
Ovarian steroidogenic response to human chorionic gonadotrophin in obese women with polycystic ovary syndrome: effect of metformin.
Human reproduction (Oxford, England) 2001;16(12):2546-51.
2001: Riitta Koivunen; Jaana Juutinen; Ilkka Vauhkonen; Laure Morin-Papunen; Aimo Ruokonen; Juha S Tapanainen
Metabolic and steroidogenic alterations related to increased frequency of polycystic ovaries in women with a history of gestational diabetes.
The Journal of clinical endocrinology and metabolism 2001;86(6):2591-9.
2000: Laure Morin-Papunen; Ilkka Vauhkonen; Riitta Koivunen; Aimo Ruokonen; Hannu Martikainen; Juha S Tapanainen
Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study.
The Journal of clinical endocrinology and metabolism 2000;85(9):3161-8.
2000: Laure Morin-Papunen; Ilkka Vauhkonen; Riitta Koivunen; Aimo Ruokonen; Juha S Tapanainen
Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome.
Human reproduction (Oxford, England) 2000;15(6):1266-74.
1998: Laure Morin-Papunen; Riitta Koivunen; Candido Tomás; Aimo Ruokonen; Hannu Martikainen
Decreased serum leptin concentrations during metformin therapy in obese women with polycystic ovary syndrome.
The Journal of clinical endocrinology and metabolism 1998;83(7):2566-8.
1998: Laure Morin-Papunen; Riitta Koivunen; Aimo Ruokonen; Hannu Martikainen
Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome.
Fertility and sterility 1998;69(4):691-6.